Hao Zeng

24PUBLICATIONS
92CO-AUTHORS
Molecular targetsRadiology and organ imagingPredictive and prognostic markersMedical virologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 28, 2026
Pretreatment intratumoral mature TLSs in non-clear cell renal cell carcinoma are associated with response to immunotherapy rechallenge.

|Sep 20, 2025
Fumarate activates the IL-6/JAK/STAT3 pathway by inhibiting KDM4C-mediated H3K36me3 demethylation in FH-knockdown renal cancer cells.

Jie Xian, Xiuyi Pan, Yifan Kang

|Aug 29, 2025
tRF-21LeuTAA Promotes Oxidative Stress by Altering Glutathione Metabolic Enzymes to Support Prostate Cancer Progression.

Xiaoyu Guo, Jinjing Zhong, Jingyu Qian

|Jul 28, 2025
First-line systemic therapy in patients with metastatic or locally advanced urothelial carcinoma: a systematic review and network meta-analysis of randomized controlled trials.

Yandong Xie, Haoyang Liu, Yanfeng Tang

|Jun 17, 2025
Quantitative Analysis With Time-Dependent Diffusion MRI for Assessing WHO/ISUP Tumor Grade in Clear Cell Renal Cell Carcinoma.

Chunlei He, Enyu Yuan, Lei Ye

|May 12, 2025
Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets.

Xingming Zhang, Junjie Zhao, Xiaoxue Yin

Pageof 4

Frequent Collaborators

9 joint publications

Ni Chen

7 joint publications

Pengfei Shen

5 joint publications

Guangxi Sun

5 joint publications

Junru Chen